These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24439949)

  • 21. Comparison of fracture risk assessment tool score to bone mineral density for estimating fracture risk in patients with advanced prostate cancer on androgen deprivation therapy.
    James H; Aleksic I; Bienz MN; Pieczonka C; Iannotta P; Albala D; Mariados N; Mouraviev V; Saad F
    Urology; 2014 Jul; 84(1):164-8. PubMed ID: 24976229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of FRAX as a determinant for risk-based osteoporosis screening may decrease unnecessary testing while improving the odds of identifying treatment candidates.
    Edwards FD; Grover ML; Cook CB; Chang YH
    Womens Health Issues; 2014; 24(6):629-34. PubMed ID: 25128036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FRAX Score Can Be Used to Avoid Superfluous DXA Scans in Detecting Osteoporosis in Celiac Disease: Accuracy of the FRAX Score in Celiac Patients.
    Tortora R; Imperatore N; Capone P; Gerbino N; Rea M; Affinito G; Caporaso N; Rispo A
    J Clin Densitom; 2018; 21(3):315-321. PubMed ID: 28625602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fracture risk prediction using phalangeal bone mineral density or FRAX(®)?-A Danish cohort study on men and women.
    Friis-Holmberg T; Rubin KH; Brixen K; Tolstrup JS; Bech M
    J Clin Densitom; 2014; 17(1):7-15. PubMed ID: 23623379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Self-perceived facture risk: factors underlying women's perception of risk for osteoporotic fractures: the Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE).
    Rothmann MJ; Ammentorp J; Bech M; Gram J; Rasmussen OW; Barkmann R; Glüer CC; Hermann AP
    Osteoporos Int; 2015 Feb; 26(2):689-97. PubMed ID: 25361616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.
    Rubin KH; Abrahamsen B; Friis-Holmberg T; Hjelmborg JV; Bech M; Hermann AP; Barkmann R; Glüer CC; Brixen K
    Bone; 2013 Sep; 56(1):16-22. PubMed ID: 23669650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of risk indices for identifying low bone mineral density and osteoporosis in Mexican Mestizo women with rheumatoid arthritis.
    Gonzalez-Lopez L; Gamez-Nava JI; Vega-Lopez A; Rodriguez-Jimenez NA; Gonzalez-Montoya N; Aguilar-Chavez E; Alcaraz-Lopez MF; Rocha-Muñoz AD; Castro-Lizano N; Morales-Romero J; Salazar-Paramo M; Suarez-Almazor ME
    J Rheumatol; 2012 Feb; 39(2):247-53. PubMed ID: 22174197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fracture risk calculated with the FRAX index in patients with osteoporosis treated and untreated].
    Roig Vilaseca D; Gómez Vaquero C; Hoces Otero C; Nolla JM
    Med Clin (Barc); 2010 Feb; 134(5):189-93. PubMed ID: 19931877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The World Health Organization Fracture Risk Assessment Tool (FRAX) underestimates incident and recurrent fractures in consecutive patients with fragility fractures.
    Roux S; Cabana F; Carrier N; Beaulieu M; April PM; Beaulieu MC; Boire G
    J Clin Endocrinol Metab; 2014 Jul; 99(7):2400-8. PubMed ID: 24780062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The fracture risk assessment tool (FRAXTM), where are we in Tunisia?].
    Zrour-Hassen S; Jguirim M; Guezguez M; Mnif H; Younes M; Bejia I; Touzi M; Abid A; Essabah H; Bergaoui N
    Tunis Med; 2011 Feb; 89(2):136-41. PubMed ID: 21308620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison fracture risk calculated by FRAX tool].
    Carranza-Lira S; Lanuza-López MC; Sandoval-Barragán MP
    Ginecol Obstet Mex; 2014 Sep; 82(9):591-4. PubMed ID: 25412552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WHO fracture risk calculator (FRAX) in the assessment of obese patients with osteoporosis.
    Franek E; Wichrowska H; Gozdowski D; Puzianowska-Kuźnicka M
    Endokrynol Pol; 2009; 60(2):82-7. PubMed ID: 19396750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
    Yu R; Leung J; Woo J
    J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis.
    Goodhand JR; Kamperidis N; Nguyen H; Wahed M; Rampton DS
    Aliment Pharmacol Ther; 2011 Mar; 33(5):551-8. PubMed ID: 21198706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Follow-up for osteoporosis in older patients three years after a fracture.
    Schurink M; Hegeman JH; Kreeftenberg HG; Ten Duis HJ
    Neth J Med; 2007 Feb; 65(2):71-4. PubMed ID: 17379932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].
    Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C
    Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FRAX without bone mineral density versus osteoporosis self-assessment screening tool as predictors of osteoporosis in primary screening of individuals aged 70 and older.
    Pang WY; Inderjeeth CA
    J Am Geriatr Soc; 2014 Mar; 62(3):442-6. PubMed ID: 24617899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the FRAX screening tool to assess fracture risk in a long-term care facility.
    Hanson L
    Consult Pharm; 2013 Jul; 28(7):426-31. PubMed ID: 23835460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FRAX and its applications in health economics--cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example.
    Ström O; Borgström F; Kleman M; McCloskey E; Odén A; Johansson H; Kanis JA
    Bone; 2010 Aug; 47(2):430-7. PubMed ID: 20493983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
    Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
    J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.